Datavault AI Fires CEO Nathaniel Bradley

Datavault AI Inc. (NASDAQ:DVLT) disclosed Thursday that its board removed CEO and President Nathaniel Bradley, effective Nov. 1, marking a leadership shake-up at the artificial intelligence company.

The board also terminated Bradley’s employment. All directors except Bradley approved the decision. Bradley voted against his removal.

Bradley Remains on Datavault AI Board

Despite losing his executive positions, Bradley remains a director.

He was elected at the company’s 2025 annual shareholder meeting. His board term runs until the next annual meeting and the election of a qualified successor, unless he resigns or is removed earlier.

The filing did not disclose a reason for Bradley’s termination or identify a replacement CEO.

Datavault AI Faces Accounting Restatement Over Bitcoin Deal

Bradley’s removal comes as Datavault faces scrutiny over accounting errors tied to a $150 million Bitcoin (CRYPTO: BTC) transaction with Scilex Holding Company (NASDAQ:SCLX).

In an Oct. 20 SEC filing, Datavault said it had incorrectly recognized Bitcoin associated with a September 2025 stock purchase agreement as a company asset.

The agreement involved 15 million common shares and warrants to purchase another 263.9 million shares in exchange for Bitcoin.

Datavault said it could not complete a requested withdrawal of Bitcoin from its Biconomy digital wallet in June 2026.

The company expects the accounting corrections to reduce previously reported assets by $92.2 million as of Dec. 31, 2025, and $49 million as of June 30, 2026.

Datavault is also reassessing its ability to continue operating as a going concern because the Bitcoin balances will no longer count as assets and collection of amounts owed by Scilex remains uncertain.

The company has not announced when it will complete the restatements.

DataMEDS AI Ends Planned Intellectual Property Deal

Adding to the developments surrounding Datavault, DataMEDS AI Inc. (NASDAQ:MEDS) announced Tuesday that it had terminated an Oct. 19 agreement involving Datavault and several other companies.

The proposed transaction involved licensing or acquiring intellectual property in exchange for DataMEDS common shares.

Other parties included REBOOT Health AI, EOS Technology Holdings, Scilex Holding Company and HealthBridge Advisors.

DataMEDS cited market conditions for the cancellation.

The company said it would no longer issue shares under the proposed transaction and would face no fees or obligations from its termination.

Existing Technology Partnerships Remain Intact

DataMEDS said its existing technology agreements remain in effect despite the canceled deal.

These include an exclusive license with REBOOT Health AI for managing users of GLP-1 medications, signed Oct. 13.

Its November 2025 agreement with Datavault AI covering PharmacyChain blockchain-enabled smart contracts also remains active.

DataMEDS confirmed that it had not issued any shares to Datavault AI under that agreement.

DVLT Price Action: Datavault AI shares rose 13.18% to $0.06 in premarket trading Friday after plunging 14.49% in the previous session, highlighting the sharp volatility often seen in micro-cap stocks, according to Benzinga Pro data.

Image via Shutterstock